– Enhanced features extend automated insulin delivery (AID) to people ages 2 years and older with type 1 diabetes and adults with type 2 diabetes – Control-IQ+ automated insulin delivery technology ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced publication by The New England Journal of Medicine ...

Global disparities in access to insulin and diabetes technologies impact glycemic outcomes in children with type 1 diabetes. Centers with universal reimbursement for diabetes technologies achieve ...

BATON ROUGE, La. (WAFB) - Over half a million people in Louisiana have diabetes, according to the American Diabetes Association. With advancements in technology, researchers say people with diabetes ...

Huawei showcased its latest wearable-based blood sugar management wellness trend insights at the World Health Expo Dubai 2026. The feature uses non-invasive Photoplethysmography (PPG) technology using ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. As a venture investor in healthcare, I am privileged to ...

A new study published in Clinical Diabetes found that people with type 1 diabetes can achieve positive results with new diabetes technology when trained by a primary care provider or through ...

ReShape Lifesciences® announced the granting of an international patent for its Diabetes Neuromodulation technology from the Australian Patent Office, providing protection until April 12, 2039. This ...

I MOSTLY SHARE ABOUT MY DIABETES JOURNEY, MY SUGARS HAVE BEEN PRETTY GOOD THE LAST THREE DAYS, SO WE LOVE THAT. THAT’S A TOTAL SLAY. LAUREN QUINN IS A TYPE ONE DIABETIC. OBVIOUSLY THE BEGINNING. IT ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced it has signed a multi-year collaboration agreement ...

– Additional data presented at the 18th International Conference on Advanced Technologies & Treatments for Diabetes – Results published in NEJM demonstrate significant improvements in time in range ...